Table 1. Demographic and clinical data of the subjects.
| Characteristics | Fatty liver (N = 350) | No fatty liver (N = 209) | p-value |
|---|---|---|---|
| Age (year) | 52.0 ± 9.9 | 51.4 ± 10.6 | 0.31 |
| Sex (female/male) | 187/163 | 123/86 | |
| BMI (kg/m2) | 27.1 ± 5.2 | 23.1 ± 3.9 | <0.001 |
| Body fat (%) | 28.2± 5.6 | 23.2 ± 3.5 | <0.001 |
| HbA1c (%) | 7.88 ± 1.21 | 7.64± 1.13 | 0.50 |
| HOMA-IR | 7.01± 2.65 | 5.45 ± 2.23 | 0.06 |
| Triglyceride (mg/dL) | 155.4 ±92.8 | 120.5 ± 56.9 | <0.001 |
| TC (mg/dL) | 183.6± 34.5 | 173.6± 31.4 | 0.02 |
| HDL- (mg/dL) | 55.5 ± 12.2 | 56.9 ± 14.8 | 0.33 |
| LDL- (mg/dL) | 96.4 ± 19.1 | 92.6 ± 30.1 | 0.20 |
| AST (U/L) | 29.1± 11.5 | 23.6 ± 12.6 | 0.02 |
| ALT (U/L) | 35.4± 22.5 | 24.2± 19.1 | <0.001 |
| HMW adiponectin (μg/ml) | 4.2±0.7 | 5.0±0.5 | <0.001 |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index;, HbA1c, glycated hemoglobin; HDL-C, high-density lipoprotein cholesterol; HMW adiponectin, high moleculae weight adiponectin; HOMA-IR, homeostasis model assessment-insulin resistance; LDL-C, low-density lipoprotein cholesterol; TC, Total cholesteral; TG, triglyceride